Flucloxacillin as an Inducer of CYP-enzymes

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 25, 2021

Primary Completion Date

December 17, 2021

Study Completion Date

December 28, 2021

Conditions
Healthy VolunteersDrug Drug Interaction
Interventions
DRUG

Flucloxacillin

Healthy volunteers will take 2x500 mg flucloxacillin 3 times a day for 31 days. The investigators will measure the baseline concentration of the 6-cocktaildrugs and flucloxacillin before start of 31 days of flucloxacillin treatment. On day 9 and 27 the investigators will measure the concentration of flucloxacillin. On day 10 and 28 the investigators will measure the concentration of the 6 cocktaildrugs

Trial Locations (1)

5000

University of Southern Denmark, Odense

All Listed Sponsors
collaborator

SignaTope GmbH, Germany

UNKNOWN

lead

University of Southern Denmark

OTHER

NCT04840641 - Flucloxacillin as an Inducer of CYP-enzymes | Biotech Hunter | Biotech Hunter